A library of probiotic bacteria and eukaryotic cells producing powerful, naturally derived antimicrobial compounds for plant and soil protection. Validated screening shows microbial biofilms that kill fungal pathogens, with identified novel genes and antimicrobial peaks matching plant terpenoids. Future work targets purified compounds, stable genetic expression, and living fertilizer coatings for industry partner validation.
This offering centers on a proprietary library of probiotic bacteria and eukaryotic cells (fungi and insects) that produce powerful antimicrobial compounds through natural, non-GMO evolutionary gene and pathway insertions. These microbes have demonstrated the ability to kill fungal pathogens individually or as consortia, making them valuable for agricultural pathogen control, seed treatment, and soil protection applications. The approach combines microbial screening, genome sequencing, and compound identification to deliver consistent, biologically derived fungicide solutions.
Key features:
The technology is at an advanced research and validation stage. Screening tests have demonstrated microbial growth under varied conditions, with cultures and extracts successfully used as plant and soil sprays and seed inoculants. Antimicrobial validation has shown that select microbes and biofilms kill fungal pathogens, and certain insect cell cultures resist contamination in antimicrobial-free conditions. Genome sequencing and HPLC-UV analysis have already identified novel genes and candidate antimicrobial peaks. Future validation will focus on growing cells under specific conditions including co-culture with Fusarium and other pathogens, purifying and testing compounds of interest against industry-selected pathogens, and cloning target genes into safe fertilizer microbes for assessment as living coatings that produce protective molecules.
Cluster Biotechnology is an Australian research and development company founded in 2015 that specializes in probiotic discovery, characterization, and improvement using molecular microbiology and genetic techniques. Headquartered at the Cohort Innovation Space in the Gold Coast Health and Knowledge Precinct, the company utilizes a team of scientists and researchers to develop innovative biotechnological products and services. Their work spans several critical areas, including agritech, food technology, public health, and therapeutic design, with a particular focus on enhancing human and animal well-being and promoting sustainable agribusiness solutions. A key innovation from the company is Foodsan, a pre-commercial probiotic biofilm coating designed to sanitize food, extend shelf life, increase nutritional value, and reduce carbon footprints. This solution is undergoing trials in multiple international markets, including Norway, Ghana, and India. By bridging the gap between scientific research and industrial application, the company aims to address real-world challenges in food security and disease prevention, while actively collaborating with academic institutions and industry partners to translate science into commercial innovation.